Alderon Biosciences

Alderon Biosciences is a biotechnology company based in Durham, North Carolina, specializing in the development of advanced diagnostic systems. The company focuses on point-of-care and molecular diagnostic technologies designed to provide rapid and sensitive detection of pathogens and biomarkers. Alderon gained significant recognition for its SARS-CoV-2 Real-Time RT-PCR Kit, which received Emergency Use Authorization (EUA) from the FDA to support testing efforts during the COVID-19 pandemic. By leveraging expertise in electrochemical sensing and molecular biology, the company aims to streamline clinical testing workflows and improve patient outcomes through decentralized diagnostics. Alderon continues to innovate in the infectious disease space, developing scalable solutions for both clinical and research environments.